Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses

Journal of Virology

Volumn 78, Issue 12, 2004, Pages 6143-6150

  Kraus, Annette A ^a   Raftery, Martin J ^a   Giese, Thomas ^b   Ulrich, Rainer ^a   Zawatzky, Rainer ^c   Hippenstiel, Stefan ^a   Suttorp, Norbert ^a   Krüger, Detlev H ^a   Schönrich, Günther ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA INTERFERON ANTIBODY; HLA ANTIGEN CLASS 1; INTERFERON ANTIBODY; MYXOVIRUS RESISTANCE PROTEIN A; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENDOTHELIUM CELL; HANTAVIRUS; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TULA VIRUS; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; CERCOPITHECUS AETHIOPS; ENDOTHELIAL CELLS; GTP-BINDING PROTEINS; HANTAAN VIRUS; HANTAVIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON-BETA; UMBILICAL VEINS; VERO CELLS; VIRUS REPLICATION;

EID: 2642567552     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.12.6143-6150.2004     Document Type: Article

References (49)

1. Chen, L. B., and W. S. Yang. 1990. Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome. J. Infect. Dis. 161:1016-1019.
2. Dhib-Jalbut, S. S., and E. P. Cowan. 1993. Direct evidence that interferon-beta mediates enhanced HLA-class I expression in measles virus-infected cells. J. Immunol. 151:6248-6258.
3. Diaz, M. O., S. Ziemin, M. M. Le Beau, P. Pitha, S. D. Smith, R. R. Chilcote, and J. D. Rowley. 1988. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA 85:5259-5263.
4. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, and G. Cheng. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17:251-263.
5. Flohr, F., S. Schneider-Schaulies, O. Haller, and G. Kochs. 1999. The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett. 463:24-28.
6. Frese, M, G. Kochs, H. Feldmann, C. Hertkorn, and O. Haller. 1996. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 70:915-923.
7. Frese, M., G. Kochs, U. Meier-Dieter, J. Siebler, and O. Haller. 1995. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J. Virol. 69:3904-3909.
8. Gao, J., B. P. De, and A. K. Banerjee. 1999. Human parainfluenza virus type 3 up-regulates major histocompatibility complex class I and II expression on respiratory epithelial cells: involvement of a STAT1- and CIITA-independent pathway. J. Virol. 73:1411-1418.
9. Garofalo, R., F. Mei, R. Espejo, G. Ye, H. Haeberle, S. Baron, P. L. Ogra, and V. E. Reyes. 1996. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-β and IL-1α. J. Immunol. 157:2506-2513.
10. Geimonen, E., S. Neff, T. Raymond, S. S. Kocer, I. N. Gavrilovskaya, and E. R. Mackow. 2002. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. USA 99:13837-13842.
11. Haller, O., M. Frese, and G. Kochs. 1998. Mx proteins: mediators of innate resistance to RNA viruses. Rev. Sci. Tech. 17:220-230.
12. Haller, O., and G. Kochs. 2003. Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3:710-717.
13. Heider, H., B. Ziaja, C. Priemer, A. Lundkvist, J. Neyts, D. H. Krüger, and R. Ulrich. 2001. A chemiluminescence detection method of hantaviral antigens in neutralisation assays and inhibitor studies. J. Virol. Methods 96:17-23.
14. Huang, C., B. Jin, M. Wang, E. Li, and C. Sun. 1994. Hemorrhagic fever with renal syndrome: relationship between pathogenesis and cellular immunity. J. Infect. Dis. 169:868-870.
15. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Investig. 52:2745-2756.
16. Jonsson, C. B., and C. S. Schmaljohn. 2001. Replication of hantaviruses. Curr. Top. Microbiol. Immunol. 256:15-32.
17. Kanerva, M., K. Melen, A. Vaheri, and I. Julkunen. 1996. Inhibition of Puumala and Tula hantaviruses in Vero cells by MxA protein. Virology 224:55-62.
18. Klempa, B., H. Meisel, S. Räth, J. Bartel, R. Ulrich, and D. H. Krüger. 2003. Occurrence of renal and pulmonary syndrome in a region of North-East Germany where Tula hantavirus circulates. J. Clin. Microbiol. 41:4894-4897.
19. Kochs, G., C. Janzen, H. Hohenberg, and O. Haller. 2002. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc. Natl. Acad. Sci. USA 99:3153-3158.
20. Krüger, D. H., R. Ulrich, and A. Lundkvist. 2001. Hantavirus infections and their prevention. Microbes Infect. 3:1129-1144.
21. Lee, H. W., and G. van der Groen. 1989. Hemorrhagic fever with renal syndrome. Prog. Med. Virol. 36:62-102.
22. Lundkvist, A., A. Fatouros, and B. Niklasson. 1991. Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies. J. Gen. Virol. 72:2097-2103.
23. Lundkvist, A., H. Meisel, D. Koletzki, H. Lankinen, F. Cifire, A. Geldmacher, C. Sibold, P. Gott, A. Vaheri, D. H. Krüger, and R. Ulrich. 2002. Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus. Viral Immunol. 15:177-192.
24. Makela, S., J. Mustonen, I. Ala-Houhala, M. Hurme, J. Partanen, O. Vapalahti, A. Vaheri, and A. Pasternack. 2002. Human leukocyte antigen-B8DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J. Infect. Dis. 186:843-846.
25. Mustonen, J., J. Partanen, M. Kanerva, K. Pietila, O. Vapalahti, A. Pasternack, and A. Vaheri. 1996. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int. 49:217-221.
26. Natarajan, K., N. Dimasi, J. Wang, R. A. Mariuzza, and D. H. Margulíes. 2002. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu. Rev. Immunol. 20:853-885.
27. Navarro, L., K. Mowen, S. Rodems, B. Weaver, N. Reich, D. Spector, and M. David. 1998. Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol. Cell. Biol. 18:3796-3802.
28. Nichol, S. T. 2001. Bunyaviruses, p. 1603-1633. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
29. Nolte, K. B., R. M. Feddersen, K. Foucar, S. R. Zaki, F. T. Koster, D. Madar, T. L. Merlin, P. J. McFeeley, E. T. Umland, and R. E. Zumwalt. 1995. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 26:110-120.
30. Pavlovic, J., T. Zurcher, O. Haller, and P. Staeheli. 1990. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64:3370-3375.
31. Pensiero, M. N., J. B. Sharefkin, C. W. Dieffenbach, and J. Hay. 1992. Hantaan virus infection of human endothelial cells. J. Virol. 66:5929-5936.
32. Peters, C. J., and S. R. Zaki. 2002. Role of the endothelium in viral hemorrhagic fevers. Crit. Care Med. 30:S268-S273.
33. Raftery, M. J., A. Kraus, R. Ulrich, D. H. Krüger, and G. Schönrich. 2002. Hantavirus infection of dendritic cells. J. Virol. 76:10724-10733.
34. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
35. Schmaljohn, C. S., and J. W. Hooper. 2001. Bunyaviridae: the viruses and their replication, p. 1581-1602. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
36. Schultze, D., A. Lundkvist, U. Blauenstein, and P. Heyman. 2002. Tula virus infection associated with fever and exanthema after a wild rodent bite. Eur. J. Clin. Microbiol. Infect. Dis. 21:304-306.
37. Sen, G. C. 2002. Viruses and interferons. Annu. Rev. Microbiol. 55:255-281.
38. Shen, J., S. S. T-To, L. Schrieber, and N. J. King. 1997. Early E-selectin, VCAM-1, ICAM-1, and late major histocompatibility complex antigen induction on human endothelial cells by flavivirus and comodulation of adhesion molecule expression by immune cytokines. J. Virol. 71:9323-9332.
39. Sibold, C., H. Meisel, D. H. Krüger, M. Labuda, J. Lysy, O. Kozuch, M. Pejcoch, A. Vaheri, and A. Plyusnin. 1999. Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J. Virol. 73:667-675.
40. Sundstrom, J. B., L. K. McMullan, C. F. Spiropoulou, W. C. Hooper, A. A. Ansari, C. J. Peters, and P. E. Rollin. 2001. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J. Virol. 75:6070-6085.
41. Taniguchi, T., and A. Takaoka. 2002. A weak signal for strong responses: interferon-alpha/beta revisited. Nat. Rev. Mol. Cell. Biol. 2:378-386.
42. Temonen, M., J. Mustonen, H. Helín, A. Pasternack, A. Vaheri, and H. Holthofer. 1996. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin. Immunol. Immunopathol. 78:47-55.
43. Temonen, M., O. Vapalahti, H. Holthofer, M. Brummer-Korvenkontio, A. Vaheri, and H. Lankinen. 1993. Susceptibility of human cells to Puumala virus infection. J. Gen. Virol. 74:515-518.
44. Thornton, S. C., S. N. Mueller, and E. M. Levine. 1983. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science 222:623-626.
45. Van Epps, H. L., M. Terajima, J. Mustonen, T. P. Arstila, E. A. Corey, A. Vaheri, and F. A. Ennis. 2002. Long-lived memory T lymphocyte responses after hantavirus infection. J. Exp. Med. 196:579-588.
46. Vapalahti, O., A. Lundkvist, S. K. Kukkonen, Y. Cheng, M. Gilljam, M. Kanerva, T. Manni, M. Pejcoch, J. Niemimaa, A. Kaikusalo, H. Henttonen, A. Vaheri, and A. Plyusnin. 1996. Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J. Gen. Virol. 77:3063-3067.
47. Weber, F., and R. M. Elliott. 2002. Antigenic drift, antigenic shift and interferon antagonists: how bunyaviruses counteract the immune system. Virus Res. 88:129-136.
48. Yousefi, S., M. R. Escobar, and C. W. Gouldin. 1985. A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory. Am. J. Clin. Pathol. 83:735-740.
49. Zaki, S. R., P. W. Greer, L. M. Coffield, C. S. Goldsmith, K. B. Nolte, K. Foucar, R. M. Feddersen, R. E. Zumwalt, G. L. Miller, and A. S. Khan. 1995. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am. J. Pathol. 146:552-579.